Does ETELCALCETIDE Cause Hyperparathyroidism secondary? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Hyperparathyroidism secondary have been filed in association with ETELCALCETIDE (PARSABIV). This represents 0.2% of all adverse event reports for ETELCALCETIDE.
6
Reports of Hyperparathyroidism secondary with ETELCALCETIDE
0.2%
of all ETELCALCETIDE reports
0
Deaths
5
Hospitalizations
How Dangerous Is Hyperparathyroidism secondary From ETELCALCETIDE?
Of the 6 reports, 5 (83.3%) required hospitalization.
Is Hyperparathyroidism secondary Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ETELCALCETIDE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does ETELCALCETIDE Cause?
Underdose (246)
Shunt stenosis (202)
Nausea (182)
Product storage error (148)
Blood parathyroid hormone increased (142)
Hypocalcaemia (140)
Shunt occlusion (126)
Blood calcium decreased (119)
Diarrhoea (107)
Vomiting (102)
What Other Drugs Cause Hyperparathyroidism secondary?
ESOMEPRAZOLE (1,357)
OMEPRAZOLE (1,274)
PANTOPRAZOLE (947)
LANSOPRAZOLE (888)
DEXLANSOPRAZOLE (382)
RABEPRAZOLE (108)
DENOSUMAB (60)
FUROSEMIDE (49)
OMEPRAZOLE\SODIUM BICARBONATE (48)
ESOMEPRAZOLE\NAPROXEN (47)
Which ETELCALCETIDE Alternatives Have Lower Hyperparathyroidism secondary Risk?
ETELCALCETIDE vs ETEPLIRSEN
ETELCALCETIDE vs ETESEVIMAB
ETELCALCETIDE vs ETHACRYNIC ACID
ETELCALCETIDE vs ETHAMBUTOL
ETELCALCETIDE vs ETHAMBUTOL\ISONIAZID\PYRAZINAMIDE\RIFAMYCIN